baber/WOPTO huggingface dataset:
Patent NZ-552486-A (NZ)
Title: Refrigeration system
Inventor: WILLIAMS THEODORE DAVID
IPC: F25D3/00
Filed: 2005-07-22
Abstract: A refrigeration system for an enclosure is provided. The system includes: a first cooling subsystem that is powered by an external source, a second cooling subsystem that is not necessarily electrically powered by an external source, a first thermal pathway by which the first cooling subsystem, when powered, cools the second cooling subsystem, a second thermal pathway by which the second cooling subsystem cools the enclosure without requiring electrical power from an external source, a controller in the second thermal pathway that operates to maintain the enclosure at a predetermined temperature, and a temperature detector in the second cooling system that determines when operation of the first cooling system is required.
Patent NZ-555038-A (NZ)
Title: Layered composition for catalyzing production of alkenyl alkanoates, comprising gold or palladium, and processes for preparing and using the composition
Inventor: BRICKER JEFFERY
IPC: C07C67/055
Filed: 2006-03-30
Abstract: Disclosed is a layered composition for catalyzing production alkenyl alkanoates, comprising an inner core, and an outer layer comprising a refractory inorganic oxide, a fibrous component, an inorganic binder; and palladium, gold, rhodium, or combinations thereof as catalytic components dispersed on the outer layer. Also disclosed is a method of producing alkenyl alkanoates comprising contact a feed of an alkene, an alkanoic acid, and an oxygen containing gas to the composition.
Patent NZ-556220-A (NZ)
Title: Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
Inventor: JONES ROBERT M
IPC: A61K31/44
Filed: 2006-01-09
Abstract: Disclosed are substituted pyridinyl and pyrimidinyl compounds of formula (Ia), or pharmaceutically acceptable salts, solvates, hydrates, enantiomers, diastereoisomers or tautomers thereof, wherein the substituents are disclosed within the specification. A method of modulating a RUP3 receptor in vitro or in a non-human animal comprising contacting the said compound with the receptor is also disclosed. Compositions comprising the said compound and an inhibitor of dipeptidyl peptidase IV (DPP-IV) are also disclosed. Use of the said compound for the manufacture of a medicament for treating metabolic-related disorders is also disclosed.
Patent NZ-560801-A (NZ)
Title: Manipulation of plant cell walls (4)
Inventor: SPANGENBERG GERMAN
IPC: C12N15/54
Filed: 2001-09-28
Abstract: Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding ferulate-5-hydroxylase (F5H) from a Lolium species.
Patent NZ-568258-A (NZ)
Title: Smart card
Inventor: HO CHUN-HSIN
IPC: G07F7/10
Filed: 2006-03-28
Abstract: A smart card (31) comprises a processor (310); a first interface for use in communication with a terminal (30); a second interface for use in communication with another smart card (32); and reset generation means for generating a reset signal (RST) (314b)for the another smart card, thereby allowing the another smart card to be controlled by the smart card. The processor further includes a buffer for receiving and saving an ATR (Answer To Reset) signal from the another smart card. The smart card can have an antenna for communication with another terminal and can comprises a SIM (Subscriber Identity Module) card, USIM (Universal Subscriber Identity Module) card, UIM (User Identity Module) card and RUIM (Removable User Identity Module) card. The smart card can be a credit card, debit card and ATM card.
Patent NZ-573538-A (NZ)
Title: Post driver safety shield whose height is controlled by the post cap which is selectively carried by the monkey
Inventor: FAIRBROTHER JAMES ERNEST
IPC: E02D7/08
Filed: 2009-12-04
Abstract: A safety shield raising mechanism for a post driver is disclosed. The postdriver is of a kind having a mast guided hammer and a mast guided post cap selectively carried or not carried upwards with the monkey. The position of the safety shield can be controlled as to its height by the post cap. When an operator moves a latching handle (39), which extends outside of the periphery of the cage, it enables an inter-engagement between the post cap and hammer so that when the post cap is lifted by the hammer the safety shield also lifts. The invention provides a postdriver which has a safety enhancement in that it denies the operator the opportunity to access the impact zone during the driving of a post since at this time the post cap remains on the post to be struck by the hammer.
Patent NZ-577573-A (NZ)
Title: Stretch releasing pressure-sensitive adhesive article which exhibits at least 40% surface contact when bonded to standard textured surface
Inventor: BRIES JAMES LEO
IPC: C09J7/29
Filed: 2007-11-30
Abstract: A stretch releasing pressure-sensitive adhesive article 80 that includes a backing 88 that includes a layer of foam having a density of from about 7 pounds per cubic foot to about 15 pounds per cubic foot, a caliper of from about 0.01 inch to less than 0.020 inch, a first major surface and a second major surface opposite the first major surface, a first pressure-sensitive adhesive composition disposed on the first major surface of the layer of foam and in direct contact with the layer of foam, and a nontacky-tab. The article 80 exhibits at least about 40% surface contact to a standardized textured surface 82.
Patent NZ-582943-A (NZ)
Title: Pharmaceutical preparations containing highly volatile silicones
Inventor: FAZEKAS PATRIK
IPC: A61K9/06
Filed: 2008-07-10
Abstract: Disclosed is a transdermal composition containing pharmaceutically active ingredient e.g. acyclovir, piroxicam, meloxicam, ibuprofen, diclofenac sodium or diclofenac potassium, clotrimazol, bifonazol, metronidazole, nifedipin, nitroglycerine or cetirizin characterised that the particles of the active ingredient are coated with highly volatile silicones e.g. hexamethyldisiloxane, octamethyltrisiloxane or decamethylpentacyclosiloxane or a mixture thereof, and these coated particles are dispersed in a gel or cream base e.g carboxyvinyl, or polymer, hydroxypropl-methylcellulose. Also disclosed is a process for the preparation of said composition.
Patent NZ-583758-A (NZ)
Title: Apoptosis promoters
Inventor: BRUNCKO MILAN
IPC: A61K31/496
Filed: 2006-05-12
Abstract: Disclosed are compounds of formula (II), wherein X4 is 1,4-oxazepan-4-yl and the other substituents are as defined in the specification. The compounds inhibit the activity of anti-apoptotic Bcl-2 family protein members and are useful in the treatment of bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer. (62) Divided Out of 561609
Patent NZ-585435-A (NZ)
Title: Pharmaceutical compositions comprising iron oxy-hydroxide
Inventor: WEIBEL LUDWIG DANIEL
IPC: A61K9/70
Filed: 2008-11-13
Abstract: Disclosed herein is a pharmaceutical composition comprising iron oxy-hydroxide in high loading of 10 to 80% (w/w) expressed in relation to the total weight of the pharmaceutical composition, in a form suitable for oral administration, wherein the amount of iron oxy-hydroxide per dosage form is >300mg. Film coated dosage forms for intact swallowing or dosage forms capable of disintegration in the oral cavity are also disclosed. Also disclosed are methods for its preparation and uses thereof in the treatment of hyperphosphataemia or patients with chronic renal insufficiency.
Patent NZ-590204-A (NZ)
Title: Immunogenic composition with 2 different bacterial capsular saccharides conjugated to a carrier protein with different linkages
Inventor: BIEMANS RALPH LEON
IPC: A61K39/116
Filed: 2006-06-23
Abstract: Provided is an immunogenic composition comprising at least 2 different bacterial capsular saccharides conjugated separately to the same type of carrier protein, wherein one or more saccharide(s) is/are conjugated to the carrier protein via a first type of chemical group on the protein carrier selected from the group consisting of carboxyl, sulphydryl, hydroxyl, imidazolyl, guanidyl and indolyl, and one or more saccharide(s) is/are conjugated to the carrier protein via a second type of chemical group on the protein carrier selected from the group consisting of amino, sulphydryl, hydroxyl, imidazolyl, guanidyl and indolyl.
Patent NZ-591854-A (NZ)
Title: Inhaler with audible indicator means and sound disabler
Inventor: BAKEWELL WILLIAM
IPC: A61M15/00
Filed: 2009-10-07
Abstract: 591854 An inhaler (2) comprising an outlet (10) through which doses of medicament may be dispensed. The inhaler also comprises a dispensing mechanism (32) having a primed state, in which it is ready for dispensing a dose, and a fired state, in which it has dispensed a dose. The inhaler also comprises a disabler (102) which, after the final dose has been dispensed, is activated to disable the dispensing mechanism from generating a sound which has been audible when the dispensing mechanism has moved from its primed state to its fired state. The disabler prevents the dispensing mechanism from being in its primed state when an outlet cover is in an open position, whereby a not ready indication is presented to the user.
Patent NZ-593177-A (NZ)
Title: Timber structural member
Inventor: THORNTON PATRICK
IPC: E04C3/12
Filed: 2009-11-09
Abstract: 593177 Disclosed is a timber structural member which includes a first timber round having a first cooperating surface extending longitudinally and a second timber round having a second cooperating surface extending longitudinally. The first cooperating surface is shaped to cooperate with the second cooperating surface and the two timber rounds are secured together to form a structurally integral unit in which the first cooperating surface is in contact with the second cooperating surface and the first timber round is substantially parallel to the second timber round. The first timber round is secured to the second timber round by a number of fasteners spaced along the length of the member. The fasteners are provided at both acute and obtuse angles in a longitudinal direction along the longitudinal axis of the structural member.
Patent NZ-593182-A (NZ)
Title: Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
Inventor: THOMAS DEBRA L
IPC: A23L29/206
Filed: 2006-12-19
Abstract: Disclosed herein is the use of â-hydroxy-â-methylbutyrate in the manufacture of a composition for treating an individual having an imbalance in type 1 and type 2 cytokine levels, wherein the condition is asthma.
Patent NZ-596806-A (NZ)
Title: Method for preparing green milk powder
Inventor: XU XINYUE
IPC: A23L19/00
Filed: 2011-03-30
Abstract: Abstract - 596806 Disclosed herein is a method of preparing a green milk powder, comprising the following steps: pretreatment, comprising cutting a plant sprout at 2~5cm above the ground when the plant sprout grows up to 25~45 cm high, washing soil and impurity away from the plant sprout surface, washing the plant sprout by ozonized sterilization running water, and then washing the plant sprout by deionized running water at room temperature, and crushing the plant sprout; filtration, comprising juicing, filtering, and extracting juice from the 10 crushed plant sprout; blend, comprising mixing the plant sprout juice and a whole milk in pre-determined proportion to uniformity until the mixture becomes a homogeneous juice; wherein the plant sprout juice is 0.1~40 % by weight of the whole milk; concentration, comprising concentrating the homogeneous juice by evaporation using an evaporator until it becomes a concentrated liquid; and drying the concentrated liquid and making it into a milk powder.
Patent NZ-599479-A (NZ)
Title: Improved reverse genetics methods for virus rescue
Inventor: KEINER BJORN
IPC: C12N7/02
Filed: 2010-10-20
Abstract: Patent No. 599479 Disclosed is a method for preparing a virus comprising the steps of (i) transfecting a culture of host cells with at least one expression construct encoding a viral RNA molecule; (ii) adding cells to the transfected host cells of (i) to provide a mixture of cells, wherein the host cells and the cells added after transfection are of the same cell line; and (iii) culturing the mixture of cells in order to produce virus.
Patent NZ-601167-A (NZ)
Title: Treatment of cardiac conditions
Inventor: LARSEN BJARNE DUE
IPC: A61P9/04
Filed: 2011-01-20
Abstract: The us of a glucagon-GLP-1 dual agonist being a positive inotropic agent in the preparation of a medicament for the treatment of heart disease or heart dysfunction.
Patent NZ-601227-A (NZ)
Title: Rail mount and method of adjustably mounting a scope to the rail of a firearm
Inventor: RILEY LOUIS F
IPC: F41G1/14
Filed: 2011-01-19
Abstract: 601227 A mounting apparatus (10) and method for adjustably mounting, for example, an optical device (82) to a rail interface (84) of a firearm (86). The apparatus (10) includes a base (18), a ring assembly (14) configured to surround and grip the device (82), and at least two spacer members (16A,16B) configured to be disposed and secured between the base (18) and ring assembly (14). The ring assembly (14) includes ring segments (32,34), a mechanism (62) for securing the ring assembly (14) to the base (18), and a mechanism (36) for securing the ring segments (32,34) together to grip the device (82) therebetween. One of the ring segments (32,34) has a support surface (54) having a shape complementary to a support surface (50) of the base (18). The spacer members (16A,16B) are configured to be secured between the base and ring assemblies (12,14), and each spacer member (16A,16B) has oppositely-disposed support surfaces (52A,52B,56A,56B) configured to complementarily engage the support surface (50,54) of either the base or ring assembly (12,14).
Patent NZ-603093-A (NZ)
Title: Patient monitoring device and method
Inventor: BAUTOVICH BASIL C
IPC: G08B21/02
Filed: 2011-03-30
Abstract: A patient monitoring device (100) and a method for operating a patient monitoring device are disclosed. The patient monitoring device (100) includes a monitoring module (101) and a proximity based token reader (105). The monitoring module includes a field generator component including at least one infrared beam sensor 4102) for generating a patient monitoring field (103). The monitoring module is configured to generate a signal in response to a breach of that field. The proximity based token reader (105) is configured for remotely reading an identifier carried by a token when that token is located within a recognition zone (107) defined relative to the proximity based token reader. The proximity based token reader is configured to assess the remotely read identifier to determined whether a shutoff condition is met, and in the case that the shutoff condition is met, transmit a shutoff signal to the monitoring module; and the monitoring module is responsive to the shutoff signal for adopting a shutoff state, in the case the shutoff condition is met the monitoring module disables the field generator component. A monitoring system for storing event data including the above described patient monitoring device and central database for receiving and storing, from the device, event data indicative of the operation of the device is disclosed. Also disclosed is a monitoring system for storing event data including the above described a patient monitoring device according to any one of the preceding claims; and one or more computers having a database for receiving and storing, from the device, event data indicative of the operation of the device.
Patent NZ-621470-A (NZ)
Title: Rebar structure and reinforced concrete member
Inventor: YOSHIFUMI NAKAMURA
IPC: E04B1/21
Filed: 2013-05-17
Abstract: Use of a reinforcing ring (10A) in rebar structure (1A) at the join of rebar reinforced concrete a column and beam is disclosed. In order to increase the allowable shearing stress (shearing proof stress) of the beam-column connecting a reinforcing member (10A) is added. The rebar structure comprises a column and a beam that are connected together. The column comprising a plurality of column longitudinal bars arranged to extend in a vertical direction and a plurality of column shear reinforcing bars arranged to surround the column longitudinal bars in a plane intersecting an axial direction of the column. The beam comprising a plurality of beam longitudinal bars arranged to extend in a horizontal direction. In a beam-column connecting portion (210) where the column and the beam are connected together, a reinforcing member (10A) having a closed form is provided to surround and to restrain the column longitudinal bars. The width (T10) of the reinforcing member in the axial direction of the column is larger than the diameter (T22) of the column shear reinforcing bars and it is spaced from an upper end and lower end of the beam-column connecting portion such that T22 less than T10 less than T0.
Patent NZ-625925-A (NZ)
Title: Process for obtaining a diesel like fuel
Inventor: WARNQVIST JAN
IPC: C11C1/08
Filed: 2012-12-07
Abstract: Disclosed is an enrichment method for obtaining components for the production of a diesel like fuel additive or a diesel like fuel from crude tall oil. In the method, lipophilic components, including fatty acids, present in said crude tall oil, are extracted with an organic solvent which may be selected from n-hexane, cyclohexane, n-heptane and petroleum diesel and the resulting extract is washed with sulfuric acid and water.
Patent NZ-627116-A (NZ)
Title: Novel antibiotic preparation method and platform system based on same
Inventor: QIU XIAOQING
IPC: C12N15/63
Filed: 2012-12-10
Abstract: Disclosed is an antibiotic preparation method, comprising steps as follows: (1) determining targets selected from prokaryotic cells, eukaryotic cells, viruses or products thereof which said antibiotic will react against directly; (2) designing a molecular structure of said antibiotic according to the formula F-R: wherein, R is a recognition region, which specifically recognizes or combines said targets; F is an effect region, which generates pharmaceutical effects in said targets, and said pharmaceutical effects are effects selected from regulating, repairing, labelling and causing death of said targets; specifically comprising ; making a recognition region molecular structure library; making an effect region molecular structure library; designing a recombinant molecular structure library using said recognition region molecular structure library and said effect region molecular structure library according to said general formula by structural readjustment, structural recombination and/or structural confirmation of the molecular structures for the recognition region; (3) using said recombinant molecular structure library to prepare and verify recombinants to obtain candidate antibiotics; (4) screening the candidates from (3) for fulfilment of requirements as a medicine to obtain antibiotics; said making a recognition region molecular structure library refers to artificially preparing artificial substances which specifically recognize and/or combine said targets as well as obtaining a molecular structure thereof; wherein said artificial substances are antibody mimetics designed according to the amino acid sequence of an immunoglobulin which can specifically recognize a unique substance on said targets.
Patent NZ-627587-A (NZ)
Title: Packaging wine in aluminium containers
Inventor: STOKES GREGORY JOHN CHARLES
IPC: C12H1/075
Filed: 2012-12-24
Abstract: A method of filling an aluminum container with wine, and an aluminum container filled with wine, characterized in that the wine has a pH between 2.9 and 3.5 and the filled aluminum container of wine has a molecular sulphur dioxide content of between 0.4 and 0.8 mg/L and further characterized in that prior to filling the wine was micro-filtered in a two stage microfiltration treatment wherein the filter pore diameters are 1.0 μm or less and at least 0.60 μm in the first stage filter housing and 0.30 μm to 0.45 μm in at least one subsequent stage filter housing.
Patent NZ-705167-A (NZ)
Title: Benzofurazan anti-amyloid compounds and methods
Inventor: REED MARK A
IPC: C07D413/04
Filed: 2013-08-22
Abstract: In general, among other things, compounds of Formula I are provided: in which R11 is selected from the group consisting of benzylamino, N-methylbenzylamino, morpholino, thiomorpholino, pyrrolidino, etc.; R13 is selected from the group consisting of 3-(1-ethanol-2-yl)phenyl, 3-(1-ol-2,2,2-trifluoroethan-2-yl)phenyl, 2-(1-ol-2,2,2-trifluoroethan-2-yl)phenyl, etc.; and R12 and R14 are each independently hydrogen or alkyl. The compounds may be used to prevent or reduce the speed of oligomerization or aggregation of amyloid proteins, such as in diseases impacted, or caused, by amyloidosis. Methods of treatment are also provided.
Patent NZ-706864-A (NZ)
Title: A nasal medication delivery device
Inventor: ATKINSON HARTLEY CAMPBELL
IPC: B05B17/06
Filed: 2015-04-09
Abstract: The invention relates to a delivery device for nasal medication. It addresses the need for delivering medication to the nose of a patient. In a preferred embodiment the device has: • A transducer 10 adapted to create an ultrasonic focal zone; • a feeder chamber 13 holding medication; • an energising chamber 14 smaller than the feeder chamber; • a mesh 15; and • an exit. The device is formed so that when it is activated the feeder chamber 13 continuously fills the energising chamber 14 with medication (until the feeder chamber has insufficient medication left to achieve this) so that there is a substantially constant supply of medication within the focal zone able to be energised and forced from the energising chamber so as to contact the mesh, become an aerosol, and leave the device by way of the exit.
Patent NZ-709739-A (NZ)
Title: Anti-il-17a antibodies and their use in treating autoimmune and inflammatory disorders
Inventor: RONDEAU JEAN-MICHEL RENE
IPC: A61K39/395
Filed: 2014-02-07
Abstract: The present disclosure relates to antibodies and proteins comprising an antigen-binding portion thereof that specifically bind to the pro-inflammatory cytokine IL-17A. The disclosure more specifically relates to specific antibodies and proteins that are IL-17A antagonists (inhibit the activities of IL-17A and IL-17AF), are capable of inhibiting IL- 17A induced cytokine production in in vitro assays, having an inhibitory effect in an antigen-induced arthritis model in vivo, and can selectively bind to homodimeric IL-17A and heterodimeric IL-17AF across several species. The disclosure further relates to compositions and methods of use for said antibodies and proteins to treat pathological disorders that can be treated by inhibiting IL-17A or IL17AF mediated activity, such as rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), lupus nephritis, chronic obstructive pulmonary disease, asthma or cystic fibrosis or other autoimmune and inflammatory disorders.
Patent NZ-712777-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23K10/32
Filed: 2007-10-26
Abstract: Disclosed is a method of changing a molecular structure of a biomass feedstock, the method comprising: preparing the biomass feedstock by reducing one or more dimensions of individual pieces of biomass; pre-treating the biomass feedstock using two or more different pre-treatment methods that each change the molecular structure, wherein the different pre-treatment methods are selected from radiation, sonication, pyrolysis, and oxidation; and processing the prepared and pre-treated biomass feedstock to produce a product.